| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |